Showing results (41-50 of 78) with videos related to
Sort By:
Pageof 8
Gynecologic Oncology|November 2, 2005
A phase II study of irofulven in women with recurrent and heavily pretreated ovarian cancerMichael V Seiden, Alan N Gordon, Diane C Bodurka, et al.Surgery|December 3, 2017
A novel reproducible model of aortic aneurysm ruptureAnna Z Fashandi, Robert B Hawkins, Morgan D Salmon, et al.Surgery|September 4, 2018
Tamsulosin attenuates abdominal aortic aneurysm growthWilliam G Montgomery, Michael D Spinosa, J Michael Cullen, et al.Biorxiv : the Preprint Server for Biology|December 23, 2024
Gut Microbiome Signatures During Acute Infection Predict Long COVIDIsin Y Comba, Ruben A T Mars, Lu Yang, et al.Angiology|June 27, 2019
Clinical Characteristics and Longitudinal Outcomes of Primary Mycotic Aortic AneurysmsJ Michael Cullen, Alexander T Booth, J Hunter Mehaffey, et al.The Journal of Surgical Research|November 9, 2019
Female Mice Exhibit Abdominal Aortic Aneurysm Protection in an Established Rupture ModelAnna Z Fashandi, Michael Spinosa, Morgan Salmon, et al.Journal of Vascular Surgery|August 22, 2018
Increased warm ischemia time during vessel harvest decreases the primary patency of cryopreserved conduits in patients undergoing lower extremity bypassJ Michael Cullen, J Hunter Mehaffey, Robert B Hawkins, et al.Carcinogenesis|October 19, 2020
HPV+ oropharyngeal squamous cell carcinomas from patients with two tumors display synchrony of viral genomes yet discordant mutational profiles and signaturesDaniel L Faden, Adam Langenbucher, Krystle Kuhs, et al.European Urology|January 6, 2020
The 111 Study: A Single-arm, Phase 3 Trial Evaluating One Cycle of Bleomycin, Etoposide, and Cisplatin as Adjuvant Chemotherapy in High-risk, Stage 1 Nonseminomatous or Combined Germ Cell Tumours of the TestisMichael Cullen, Robert Huddart, Johnathan Joffe, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2004
Characterization and multiparameter analysis of visual adverse events in irofulven single-agent phase I and II trialsEric Raymond, Carmen Kahatt, Marie Hélène Rigolet, et al.Pageof 8